Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve and take on record ....
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Entero Healthcare Solutions has informed the stock exchanges that its Board of Directors will meet on Thursday, February 12, 2026. The key agenda is to consider, approve, and take on record the Unaudited Standalone and Consolidated Financial Results (along with Limited Review) for the quarter and nine months ended December 31, 2025. The trading window for designated persons has been closed since January 1, 2026 and will remain closed until 48 hours after the results are declared. This is a standard regulatory disclosure under SEBI LODR Regulation 29 ahead of the quarterly results announcement.
No direct impact on shareholders from this filing — it is a procedural notice. Investors should watch the actual Q3FY26 results on or after February 12, 2026 for insights into revenue, margins, and profitability trends.